Arca
Skip to content
Tools
Tools

CA4: Carbonic anhydrase 4

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Catalyzes the reversible hydration of carbon dioxide into bicarbonate and protons and thus is essential to maintaining intracellular and extracellular pH.

  • Drugs that act on it: 4
  • Approved: 4
  • In phases 1 to 3: 0
  • Sponsors: 4

Who Is On It, and How Far Along

Every drug ChEMBL records acting on CA4, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved4

  • Acetazolamide
  • Topiramate
  • Methazolamide
  • Dichlorphenamide

Phase 30

    Phase 20

      Phase 10

        Sponsors

        Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

        Modalities

        Drugs on this target by ChEMBL molecule type.

        • Small molecule4100%

        The Landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Carbonic anhydrase IV inhibitor.
        AcetazolamideApprovedIncannex Healthcare LtdSmall moleculeInhibitor—43Boxed warning
        TopiramateApprovedJohnson & JohnsonSmall moleculeInhibitor—31—
        MethazolamideApprovedPfizerSmall moleculeInhibitor—1—
        DichlorphenamideApprovedXeris PharmaceuticalsSmall moleculeInhibitor—0—

        Open Trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 16 in all, from ClinicalTrials.gov.
        Natriuresis With Acetazolamide or SGLT2 Inhibitors Added to Intravenous Loop Diuretics in Decompensated Heart FailureAcetazolamidePhase 4Active, not recruitingUniversidade do Porto2026-11-09
        Adding Acetazolamide on Top of SGLT2 Inhibition in Persons With Type 2 DiabetesAcetazolamidePhase 2Not yet recruitingUniversity Health Network, Toronto2026-10-29
        Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1sTopiramatePhase 4Not yet recruitingJing Luo2026-09-21
        Discontinuing Psychotropic Medication Before Psychotherapy for PTSDTopiramate—Not yet recruitingAcademic Centre for Dentistry in Amsterdam2026-09-03
        Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and LymphomaTopiramatePhase 2Not yet recruitingSt. Jude Children's Research Hospital2026-08-27
        ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.AcetazolamidePhase 3Not yet recruitingUniversity Hospital, Montpellier2026-07-30
        Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity PharmacotherapyTopiramateNot applicableNot yet recruitingPhenomix Sciences2026-07-27
        Idiopathic Intracranial Hypertension: Prognostic Factors and Multidisciplinary ManagementTopiramate, AcetazolamideNot applicableActive, not recruitingSohag University2026-07-16
        Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)TopiramatePhase 4Not yet recruitingStanford University2026-06-17
        DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.AcetazolamidePhase 2RecruitingIncannex Healthcare Ltd2026-06-09
        TACTIC-HF: Sequential Diuretic Strategies in Ambulatory Worsening Heart FailureAcetazolamidePhase 4Not yet recruitingLucrecia Maria Burgos2026-05-18
        The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High AltitudeAcetazolamideEarly phase 1Active, not recruitingUniversity of California, Riverside2026-04-08
        Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging StudyAcetazolamide—RecruitingCopenhagen University Hospital, Rigshospitalet2026-03-19
        Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord StimulationTopiramate—RecruitingBrai²n2026-02-17
        Combining Latency Reversing Agents to Address the HIV ReservoirTopiramatePhase 1 / Phase 2Not yet recruitingErasmus Medical Center2026-02-03
        Use of Methazolamide to Lower Intraocular PressureMethazolamidePhase 4Active, not recruitingUniversity of Colorado, Denver2022-08-11

        Diseases Most Associated With It

        Open Targets association score, 0 to 1; all associations
        Seizure
        0.59
        Angle-closure glaucoma
        0.59
        Altitude sickness
        0.59
        Edema
        0.59
        Alcohol dependence
        0.56
        Neurodegenerative disease
        0.44
        Obesity disorder
        0.41

        Genes and Related Targets

        Complexes and families that share a gene with this target
        Genes
        CA4

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3729, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P22748, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.